News
LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc.
LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc.
$LABT - Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
Lakewood-Amedex Biotherapeutics shares rose 12.6% following a CEO letter to shareholders that highlighted transformational progress and the outlook for the company's Nu-3 program. The positive messaging about advancement in the pipeline candidate appears to have boosted investor confidence in the biotech firm's direction.
21-SEP-2026 08:02 AM ET
Share this post
More filings for $LABT
LABT ▲ +10.8% - Lakewood-Amedex Biotherapeutics, Inc.Nov 9, 2026LABT ▲ +5.0% - Lakewood-Amedex Biotherapeutics, Inc.Nov 5, 2026LABT ▲ +8.6% - Lakewood-Amedex Biotherapeutics, Inc.Oct 21, 2026LABT ▼ -6.9% - Lakewood-Amedex Biotherapeutics, Inc.Oct 7, 2026LABT ▼ -5.3% - Lakewood-Amedex Biotherapeutics, Inc.Oct 1, 2026LABT ▲ +99.4% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026
View full $LABT filing history →💬 Comments
Loading comments…
Leave a comment
